Nasser Albogami
Papers
1
Total Citations
3
H-Index
1
About
Dr. Nasser Albogami is a urologic oncologist whose research focuses on optimizing surgical management for renal cell carcinoma (RCC), particularly in complex, locally advanced cases. His major contributions center on challenging conventional treatment paradigms by investigating the safety and efficacy of nephron-sparing surgery in higher-risk patients. In his highly relevant 2023 study, "Preserving Renal Function without Compromising Oncological Outcomes," Dr. Albogami conducted a comparative analysis of partial versus total nephrectomies specifically for T3 stage RCC. This work provides critical evidence that partial nephrectomy may be a viable option for select patients with locally advanced disease, offering the dual benefit of preserving renal function without sacrificing oncological control. While his citation count is currently building, this paper represents a significant contribution to the ongoing debate in urologic oncology. Dr. Albogami’s research is particularly valuable for surgeons and trainees seeking to expand the indications for kidney-sparing surgery, ultimately aiming to improve long-term quality of life for patients facing aggressive renal tumors.
Research Focus
Key Achievements
Top Papers
- 1